Accurate axillary lymph node dissection is feasible after neoadjuvant chemotherapy

Am J Surg. 2009 Jul;198(1):46-50. doi: 10.1016/j.amjsurg.2008.05.006. Epub 2008 Dec 17.

Abstract

Background: Recently, lower axillary lymph node retrieval after neoadjuvant chemotherapy was reported. We did not have this experience, and retrospectively analyzed our axillary lymph node dissections (ALNDs).

Methods: One hundred ninety-one patients who had ALND after neoadjuvant chemotherapy were compared with 192 patients with primary ALND after a positive sentinel node biopsy.

Results: There were no differences in the mean number of nodes retrieved between the neoadjuvant group and the primary surgery group: 16.3 (range 4-38) and 15.8 (range 6-33), respectively (P = .4); or in the retrieval of fewer than 10 lymph nodes: 13/191 (7%) and 11/192 (6%) (P = .7). The number of cases with retrieval of more than 20 lymph nodes was higher in the neoadjuvant group: 42/191 (22%) versus 26/192 (13%) (P = .03). In the neoadjuvant group, 150/191 (79%) patients had residual lymph node metastasis after neoadjuvant chemotherapy.

Conclusion: Our results show the feasibility and need to remove enough lymph nodes to provide precise prognostic information and adequate local control.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anthracyclines / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Axilla
  • Biopsy, Fine-Needle
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / secondary
  • Breast Neoplasms / surgery
  • Bridged-Ring Compounds / therapeutic use
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Humans
  • Lymph Node Excision / standards*
  • Lymph Nodes / pathology*
  • Lymph Nodes / surgery
  • Lymphatic Metastasis
  • Mastectomy / methods
  • Middle Aged
  • Neoadjuvant Therapy / methods*
  • Reproducibility of Results
  • Retrospective Studies
  • Taxoids / therapeutic use
  • Time Factors
  • Young Adult

Substances

  • Anthracyclines
  • Antineoplastic Agents
  • Bridged-Ring Compounds
  • Taxoids
  • taxane